04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
Two key provisions included in the Coronavirus Aid, Relief and Economic Security Act (the “CARES Ac...
Read More >
On April 30, 2018, the California Supreme Court issued its landmark Dynamex decision, applying a new...
Read More >
The U.S. District Court for the District of Massachusetts denied conditional class action certificat...
Read More >
U.S. immigration law is a complicated legal area that requires the services of exceptional employmen...
Read More >
On November 7, 2019, a bill was introduced in the New Jersey legislature that would, like California...
Read More >
In the wake of the COVID-19 crisis, many companies will be facing significant financial difficulties...
Read More >